MedWatch

Deloitte: Life Science should move into other emerging markets

Deloitte believes that an increased focus on other emerging markets than the BRIC countries would be a sound move for Danish companies in the Life Science industry.

Foto: PR Foto

Life Science companies should bear in mind that there are other emerging markets than the BRIC countries and make sure they are locally present, if they want to succeed, says the professional services firm Deloitte.

The conclusion appears in a recently published survey of growth strategies from the firm focusing on the Next11 countries, which are Egypt, Pakistan, Indonesia, Iran Turkey, Vietnam, the Philippines, Nigeria, Bangladesh, Mexico and South Korea.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier